Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a Minnesota-based medical device company focused on fully implantable hearing solutions, best known for its Acclaim Cochlear Implant System. The company completed its SPAC business combination and began trading under the COCH ticker in 2023, transitioning from a private development-stage entity to a publicly listed commercial-stage business within the medical technology sector. Its August 2023 Form 10-Q filing reflects its initial quarters as a public company, capturing early post-merger operational and financial activity. Envoy Medical operates in the hearing health and implantable device segment, competing in a market that spans both cochlear and middle ear implant technologies. Sign up on SpacDesk for full filings, deal timelines, and sponsor data on COCH and hundreds of other SPAC transactions.